| In search of a novel target—Phosphatidylserine exposed by non-apoptotic tumor cells and metastases of malignancies with poor treatment efficacy S Riedl, B Rinner, M Asslaber, H Schaider, S Walzer, A Novak, K Lohner, ... Biochimica et Biophysica Acta (BBA)-Biomembranes 1808 (11), 2638-2645, 2011 | 359 | 2011 |
| Low-level monocyte chemoattractant protein-1 stimulation of monocytes leads to tumor formation in nontumorigenic melanoma cells M Nesbit, H Schaider, TH Miller, M Herlyn The Journal of Immunology 166 (11), 6483-6490, 2001 | 297 | 2001 |
| Downregulation of E-cadherin and Desmoglein 1 by autocrine hepatocyte growth factor during melanoma development G Li, H Schaider, K Satyamoorthy, Y Hanakawa, K Hashimoto, M Herlyn Oncogene 20 (56), 8125-8135, 2001 | 286 | 2001 |
| Nongenital cancers metastatic to the ovary E Petru, H Pickel, M Heydarfadai, M Lahousen, J Haas, H Schaider, ... Gynecologic oncology 44 (1), 83-86, 1992 | 234 | 1992 |
| Transforming growth factor-β1 increases survival of human melanoma through stroma remodeling C Berking, R Takemoto, H Schaider, L Showe, K Satyamoorthy, ... Cancer research 61 (22), 8306-8316, 2001 | 224 | 2001 |
| Differential response of primary and metastatic melanomas to neutrophils attracted by IL‐8 H Schaider, M Oka, T Bogenrieder, M Nesbit, K Satyamoorthy, C Berking, ... International Journal of Cancer 103 (3), 335-343, 2003 | 186 | 2003 |
| Transcriptional activation of ZEB1 by Slug leads to cooperative regulation of the epithelial–mesenchymal transition-like phenotype in melanoma C Wels, S Joshi, P Koefinger, H Bergler, H Schaider Journal of investigative dermatology 131 (9), 1877-1885, 2011 | 182 | 2011 |
| Interleukin-8 overexpression is present in pyoderma gangrenosum ulcers and leads to ulcer formation in human skin xenografts M Oka, C Berking, M Nesbit, K Satyamoorthy, H Schaider, G Murphy, ... Laboratory investigation 80 (4), 595-604, 2000 | 152 | 2000 |
| A stress-induced early innate response causes multidrug tolerance in melanoma D Ravindran Menon, S Das, C Krepler, A Vultur, B Rinner, S Schauer, ... Oncogene 34 (34), 4448-4459, 2015 | 135 | 2015 |
| Tumoural CXCL16 expression is a novel prognostic marker of longer survival times in renal cell cancer patients P Gutwein, A Schramme, N Sinke, MS Abdel-Bakky, B Voss, N Obermüller, ... European journal of cancer 45 (3), 478-489, 2009 | 129 | 2009 |
| Tumor-associated B-cells induce tumor heterogeneity and therapy resistance R Somasundaram, G Zhang, M Fukunaga-Kalabis, M Perego, C Krepler, ... Nature communications 8 (1), 607, 2017 | 128 | 2017 |
| Deletion analysis of the p16 tumor suppressor gene in gastrointestinal mucosa-associated lymphoid tissue lymphomas P Neumeister, G Hoefler, C Beham-Schmid, H Schmidt, U Apfelbeck, ... Gastroenterology 112 (6), 1871-1875, 1997 | 110 | 1997 |
| Naphthoquinones from Onosma paniculata Induce Cell-Cycle Arrest and Apoptosis in Melanoma Cells N Kretschmer, B Rinner, AJA Deutsch, B Lohberger, H Knausz, O Kunert, ... Journal of natural products 75 (5), 865-869, 2012 | 106 | 2012 |
| Chemokine receptors in gastric MALT lymphoma: loss of CXCR4 and upregulation of CXCR7 is associated with progression to diffuse large B-cell lymphoma AJA Deutsch, E Steinbauer, NA Hofmann, D Strunk, T Gerlza, ... Modern Pathology 26 (2), 182-194, 2013 | 97 | 2013 |
| A systematic review of non‐surgical treatments for lentigo maligna T Read, C Noonan, M David, M Wagels, M Foote, H Schaider, HP Soyer, ... Journal of the European Academy of Dermatology and Venereology 30 (5), 748-753, 2016 | 76 | 2016 |
| Profiles of chemokine receptors in melanocytic lesions: de novo expression of CXCR6 in melanoma H Seidl, E Richtig, H Tilz, M Stefan, U Schmidbauer, M Asslaber, ... Human pathology 38 (5), 768-780, 2007 | 74 | 2007 |
| Emerging roles of H3K9me3, SETDB1 and SETDB2 in therapy-induced cellular reprogramming J Torrano, A Al Emran, H Hammerlindl, H Schaider Clinical epigenetics 11, 1-14, 2019 | 63 | 2019 |
| Human lactoferricin derived di-peptides deploying loop structures induce apoptosis specifically in cancer cells through targeting membranous phosphatidylserine S Riedl, R Leber, B Rinner, H Schaider, K Lohner, D Zweytick Biochimica et Biophysica Acta (BBA)-Biomembranes 1848 (11), 2918-2931, 2015 | 62 | 2015 |
| Distinct histone modifications denote early stress-induced drug tolerance in cancer A Al Emran, DM Marzese, DR Menon, MS Stark, J Torrano, ... Oncotarget 9 (9), 8206, 2018 | 60 | 2018 |
| Stroma formation and angiogenesis by overexpression of growth factors, cytokines, and proteolytic enzymes in human skin grafted to SCID mice CJ Gruss, K Satyamoorthy, C Berking, J Lininger, M Nesbit, H Schaider, ... Journal of investigative dermatology 120 (4), 683-692, 2003 | 57 | 2003 |
